Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Revenue

In the fiscal year ending March 31, 2026, Orchid Pharma had annual revenue of 8.11B INR, down -12.00%. Orchid Pharma had revenue of 2.38B in the quarter ending March 31, 2026, with 0.05% growth.

• Revenue: 8.11B
• Revenue Growth: -12.00%
• P/S Ratio: 6.12
• Revenue / Employee: 11.02M
• Employees: 736
• Market Cap: 49.66B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	8.11B	-1.11B	-12.00%
Mar 31, 2025	9.22B	1.03B	12.52%
Mar 31, 2024	8.19B	1.53B	23.05%
Mar 31, 2023	6.66B	1.06B	19.00%
Mar 31, 2022	5.60B	1.09B	24.33%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error